Every 424B that Nuburu, Inc. (BURU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BURU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BURU filings page.
Nuburu, Inc. is conducting a best efforts public offering of 117,365,368 shares of common stock and 127,007,616 pre-funded warrants, sold together with 733,853 shares of Series B preferred stock, plus up to 205,627,016 common shares issuable upon warrant exercise and preferred conversion.
The combined public offering price is $0.1555 per common share and accompanying 0.003003 Series B share (or $0.1554 per pre-funded warrant unit), implying maximum gross proceeds of $38,000,000, placement fees of $2,375,000 and proceeds before expenses of $35,625,000. Common shares outstanding were 249,042,796 as of July 10, 2026 and would be 366,408,164 after the offering, excluding warrant exercises and preferred conversions.
Proceeds are earmarked for working capital, strategic investments and acquisitions under Nuburu’s Transformation Plan, and repayment of a YA debenture and $1.25 million of Lyocon-related convertible notes. The company highlights ongoing losses, liquidity constraints, significant potential dilution, NYSE American listing risk, and uncertainty around closing key acquisitions.
Nuburu, Inc. files a prospectus to register for resale up to 60,000,000 shares of Common Stock by YA II PN, LTD. The resale registration covers Offered Shares issued or issuable under a Standby Equity Purchase Agreement (SEPA). The prospectus states the Company will receive no proceeds from resales by the Selling Stockholder; however, sales to the Selling Stockholder under the SEPA could generate up to $11.6 million of aggregate gross proceeds based on the April 20, 2026 closing price, subject to SEPA terms and repayment of a $25,000,000 debenture. Shares outstanding were 169,497,579 as of April 20, 2026.
Nuburu, Inc. is conducting a best efforts public offering of 58,379,137 shares of common stock and 50,711,772 pre-funded warrants, plus common warrants exercisable for up to 163,636,364 shares. The securities are priced at $0.11 per share and accompanying warrant (or $0.1099 per pre-funded warrant and warrant), targeting $12,000,000 in gross proceeds and about $11,130,000 in net proceeds before expenses.
The company warns investors of immediate and substantial dilution, no public market for the warrants, and that this is a no‑minimum, best efforts deal. Nuburu discloses severe liquidity constraints, a transformation plan focused on acquisitions and licensing after a foreclosure on its patent portfolio, and preliminary 2025 figures indicating an estimated net loss of $78.7 million and a stockholders’ deficit. The filing highlights substantial going‑concern risks, heavy use of convertible instruments and warrants, and potential NYSE American delisting if listing standards are not maintained.
Nuburu, Inc. is registering up to 230 million shares of common stock for resale by YA II PN, LTD., the selling stockholder from a recent financing. These shares are tied to a $25,000,000 debenture and four warrant series that together cover 230,000,000 warrant shares with exercise prices ranging from $0.01 to $0.47 per share. Nuburu will not receive proceeds from resales, but could receive cash if the warrants are exercised, which could total about $46,925,000 before fees if all are exercised in cash.
The company completed this financing after a going‑concern qualified audit opinion and continues to report large accumulated losses. A 19.99% NYSE American “Exchange Cap” and a 4.99% beneficial ownership limit restrict how many shares can be issued to the selling stockholder without shareholder approval. Nuburu also has a $100,000,000 standby equity purchase agreement that can direct all proceeds to repaying the debenture, and warns that extensive past and potential future share issuances may significantly dilute existing holders and pressure the stock price.
Nuburu, Inc. is registering up to 130 million shares of common stock for resale by a single selling stockholder under a standby equity purchase agreement. These shares may be issued to YA II PN, LTD under a $100 million equity facility that Nuburu can draw on at its discretion, with purchase prices based on a discount to recent volume-weighted average trading prices.
Nuburu will not receive proceeds from the resale of these shares, though it may raise capital by selling new shares to the investor under the agreement. As of December 8, 2025, 437,987,341 shares of common stock were outstanding.
The company highlights significant risks: potential substantial dilution and share price pressure from multiple financing and resale transactions, a history of substantial losses and going‑concern uncertainty, dependence on closing several planned acquisitions, and the need for additional capital to execute its transformation strategy. Nuburu has received a NYSE American noncompliance notice and has previously restated financial statements and identified material weaknesses in internal controls.